CN103989744A - Medicinal liquor for treating fracture as well as preparation method and application of medicinal liquor - Google Patents
Medicinal liquor for treating fracture as well as preparation method and application of medicinal liquor Download PDFInfo
- Publication number
- CN103989744A CN103989744A CN201410256869.2A CN201410256869A CN103989744A CN 103989744 A CN103989744 A CN 103989744A CN 201410256869 A CN201410256869 A CN 201410256869A CN 103989744 A CN103989744 A CN 103989744A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicinal liquor
- medicated wine
- fracture
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides medicinal liquor for treating fracture. The medicinal liquor is prepared from the following raw materials in parts by weight: 20-30 parts of obovateleaf actinodaphne bark, 15-25 parts of Euchresta japonica, 8-12 parts of all-grass of Tali Lobelia, 8-12 parts of lanceleaf magnoliavine herb, 10-14 parts of rhizoma drynariae and 18-22 parts of the root of three-nerved spicebush. The aim of treating fracture is achieved through the aims of strengthening tendons and bones, dispelling wind and eliminating dampness, promoting blood circulation to remove blood stasis and eliminating stagnation stop pain. The invention also discloses a preparation method and application of the medicinal liquor.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of medicated wine that is used for the treatment of fracture and its preparation method and application.
Background technology
Fracture refers to a kind of disease that causes sclerotin partially or completely to rupture due to reasons such as wound or pathology.Its main clinical manifestation is: fractures has limitation pain pain and tenderness, local swelling and occur ecchymosis, and limb function position or completely lose, still can there is cacomelia and abnormal movement in completeness sclerotin.
The medicated wine for the treatment of fracture at present, most of flavour of a drug are selected single, and mouthfeel is poor, can not obtain good therapeutic effect.For better treatment disease, pain and alleviation, make patient's body tissue early recovery, people in the urgent need to a kind of effective, oneself is by most people confirms to play that strengthening the tendons and bones, invigorating blood circulation are tired, the treatment of the good result of dredge the meridian passage, reducing swelling and alleviating pain is fractured medicated wine.
Summary of the invention
Goal of the invention: in order to address the above problem, the object of the present invention is to provide a kind of medicated wine that is used for the treatment of fracture and its preparation method and application.
Technical scheme: the object of the invention is to realize by following scheme:
A medicated wine that is used for the treatment of fracture, it is prepared by the raw material of following parts by weight: Cortex Actinodaphnes Obovatae 20-30 part, bean leaf seven 15-25 parts, Herba Lobeliae taliensis 8-12 part, Herba Schisandrae lancifoliae 8-12 part, Rhizoma Drynariae 10-14 part, Radix Linderae 18-22 part.
The described medicated wine that is used for the treatment of fracture, it is prepared by the raw material of following parts by weight: 25 parts of Cortex Actinodaphnes Obovataes, 7 20 parts, bean leaf, 10 parts of Herba Lobeliae taliensis, 10 parts of Herba Schisandrae lancifoliaes, 8 parts of Sanguis Draxonis, 12 parts of Rhizoma Drynariae, 20 parts of the Radixs Linderae.
The described medicated wine that is used for the treatment of fracture, preparation method comprises the steps: to get Cortex Actinodaphnes Obovatae, bean leaf seven, Herba Lobeliae taliensis, Herba Schisandrae lancifoliae, Rhizoma Drynariae, the merging of Radix Linderae medical material, add 35-50 degree soaking in Chinese liquor 20 days, Chinese liquor consumption is 20 times of medical material weight, obtains medicated wine.
Application in the medicated wine that the described medicated wine that is used for the treatment of fracture is fractured in preparation treatment.
Cortex Actinodaphnes Obovatae is the yellow meat nanmu of Lauraceae Actinodaphne plant Acanthopanax obovatus Hoo Actinodaphne obovata Blume, and the bark of take is used as medicine, bean leaf seven is Crassulaceae Rhodida plant Rhodiola yunnanensis Rhodiola yunnanensis (Franch.) Fu[Sedum yunnanense Franch.; S.valerianoides Diels], take all herbal medicine, Herba Lobeliae taliensis is campanulaceae Herba Lobeliae taliensis Lobelia hybrida C.Y.Wu, take all herbal medicine, Herba Schisandrae lancifoliae is the Herb as Magnoliacea plant lanceleaf magnoliavine fruit.
Beneficial effect:
From theory of Chinese medical science, Cortex Actinodaphnes Obovatae promoting flow of qi by warming channel, synthetism in we, bean leaf seven anti-inflammation detumescences, synthetism, both are monarch drug, and Herba Lobeliae taliensis stopping bleeding and knitting the fractured bone, Herba Schisandrae lancifoliae removing blood stasis to reduce swelling, both are ministerial drug, promote the synthetism effect of monarch drug, the drug for invigorating blood circulation and eliminating stasis such as Rhizoma Drynariae, the Radix Linderae is adjuvant, all medicines are harmonious, and play altogether that strengthening the tendons and bones, invigorating blood circulation are tired, dredge the meridian passage, reducing swelling and alleviating pain effect, are used for the treatment of fracture.Theory of Chinese medical science is thought injury blood stasis swelling, blockage of main and collateral channels, and QI and blood retardance, treatment should be with blood circulation promoting and blood stasis dispelling, and circulation of qi promoting is dissipated as master.Formulation is reasonable, and compatibility is rigorous, through long-term clinical verification, determined curative effect.Consist of Chinese crude drug, have no side effect, low price.
The specific embodiment
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as to the scope of the above-mentioned theme of the present invention only limits to following example, all technology realizing based on foregoing of the present invention all belong to scope of the present invention.
1. Preparation Example
Embodiment 1: get 25 parts of Cortex Actinodaphnes Obovataes, 7 20 parts, bean leaf, 10 parts of Herba Lobeliae taliensis, 10 parts of Herba Schisandrae lancifoliaes, 8 parts of Sanguis Draxonis, 12 parts of Rhizoma Drynariae, 20 parts of medical materials merging of the Radix Linderae, add 40 degree soaking in Chinese liquor 20 days, Chinese liquor consumption is 20 times of medical material weight, obtains medicated wine.
2. the pharmacodynamic study on the impact of the bone density of laboratory animal
Sample preparation: prepare test specimen by above-described embodiment 1, specification is 100ml/ bottle is 30g/ bottle containing crude drug amount.Precious strong SHENGU JIAONANG, Shandong meeting elixir industry Group Co.,Ltd, lot number: 20120711.Tretinoin sheet, Shandong Liang Fu pharmaceutical Co. Ltd, lot number: 20110120
Animal: W istar rat, male, body weight 180-240g, Shanghai Slac Experimental Animal Co., Ltd. provides.
The foundation of experiment grouping and model rat with osteoporosis: get 30 of normal W istar rats and be divided at random 5 groups, getting wherein 6 is NS group; Get wherein 6 as model group, press merely tretinoin 70mg/kg gavage two weeks; Get wherein 6 precious strong SHENGU JIAONANG matched groups of conduct; Remaining 12 rats are as the high low dose group of the present invention.When gavaging tretinoin as ZHENMUSHENGU JIAONANG matched group and high and low dose group of the present invention by the dosage of 70mg/kg, gavage corresponding medicine, withdraw tretinoin after gavaging two weeks and continue two weeks and measure indices.Rat sacrificed by decapitation, gets its femur and arranges by group, uses X-line mammary gland video camera production mating plate, the 5 positions bone density value of fixing a point to measure and record on the greater trochanter of femur, femoral head, neck of femur, intertrochanteric line and under intertrochanteric line with black and white densimeter.
The impact of the present invention on rat bone density
With model group comparison, * 1P<0.01, * 2P<0.05
Experimental result shows, the present invention and model group comparison, have significant difference, illustrates that the present invention can improve bone density, treatment fracture, and also effect is better than precious strong SHENGU JIAONANG.
3. model case
Case 1: Lee, man, 40 years old.Injured be in hospital, clinical diagnosis is right lower extremity fracture, the therapeutic scheme of employing is as follows: take the above embodiment of the present invention 1 preparation clinical trial sample, each 20ml, every day 3 times, is discharged from hospital after recovery after serveing on six weeks.
Case 2: Zhang, female, 48 years old.Patient is injured to be in hospital, and clinical diagnosis is that right chi is scratched bone fracture, takes the above embodiment of the present invention 1 preparation clinical trial sample, and each 20ml, is discharged from hospital after recovery after the bimester of serveing at every day 3 times.
Claims (4)
1. a medicated wine that is used for the treatment of fracture, is characterized in that, it is prepared by the raw material of following parts by weight: Cortex Actinodaphnes Obovatae 20-30 part, bean leaf seven 15-25 parts, Herba Lobeliae taliensis 8-12 part, Herba Schisandrae lancifoliae 8-12 part, Rhizoma Drynariae 10-14 part, Radix Linderae 18-22 part.
2. the medicated wine that is used for the treatment of fracture according to claim 1, it is characterized in that, it is prepared by the raw material of following parts by weight: 25 parts of Cortex Actinodaphnes Obovataes, 7 20 parts, bean leaf, 10 parts of Herba Lobeliae taliensis, 10 parts of Herba Schisandrae lancifoliaes, 8 parts of Sanguis Draxonis, 12 parts of Rhizoma Drynariae, 20 parts of the Radixs Linderae.
3. the medicated wine that is used for the treatment of fracture according to claim 1, it is characterized in that, preparation method comprises the steps: to get Cortex Actinodaphnes Obovatae, bean leaf seven, Herba Lobeliae taliensis, Herba Schisandrae lancifoliae, Rhizoma Drynariae, the merging of Radix Linderae medical material, add 35-50 degree soaking in Chinese liquor 20 days, Chinese liquor consumption is 20 times of medical material weight, obtains medicated wine.
4. the medicated wine that is used for the treatment of fracture described in claim 1 or 2 is treated the application in the medicated wine of fracturing in preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410256869.2A CN103989744A (en) | 2014-06-11 | 2014-06-11 | Medicinal liquor for treating fracture as well as preparation method and application of medicinal liquor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410256869.2A CN103989744A (en) | 2014-06-11 | 2014-06-11 | Medicinal liquor for treating fracture as well as preparation method and application of medicinal liquor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103989744A true CN103989744A (en) | 2014-08-20 |
Family
ID=51304245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410256869.2A Pending CN103989744A (en) | 2014-06-11 | 2014-06-11 | Medicinal liquor for treating fracture as well as preparation method and application of medicinal liquor |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103989744A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106511561A (en) * | 2017-01-12 | 2017-03-22 | 李婷婷 | Medicinal liquor capable of promoting fracture healing and preparation method thereof |
-
2014
- 2014-06-11 CN CN201410256869.2A patent/CN103989744A/en active Pending
Non-Patent Citations (3)
| Title |
|---|
| 云南省卫生局革命委员会: "《云南中草药》", 28 February 1972, 云南人民出版社 * |
| 田元春等: "十一方药酒对大鼠实验性骨折的影响", 《中国医院药学杂志》 * |
| 黄小荣等: "《草药治疗骨伤》", 31 May 1999, 福建科学技术出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106511561A (en) * | 2017-01-12 | 2017-03-22 | 李婷婷 | Medicinal liquor capable of promoting fracture healing and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103156972B (en) | Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury | |
| CN101129973A (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
| CN102698092B (en) | Traditional Chinese medicine composition for treating liver-Yang hyperactivity-type hypertension | |
| CN104873898A (en) | Preparation, namely blood conducting powder containing kudzuvine root and safflower, for treating hemiplegia | |
| CN102274370B (en) | Traditional Chinese medicine composition for treating fracture | |
| CN103230492A (en) | Traditional Chinese medicine external ointment for treating traumatic injury and fracture | |
| CN103800489A (en) | Traditional Chinese medicine wine for treating cervical spondylosis and preparation method of traditional Chinese medicine wine | |
| CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
| CN102283917B (en) | Deer bone medicated liquor for treating fracture | |
| CN104587225A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN103989744A (en) | Medicinal liquor for treating fracture as well as preparation method and application of medicinal liquor | |
| CN104258308A (en) | Traditional Chinese medicine preparation for treating cholelithiasis | |
| CN104523879A (en) | Medicinal wine with effect of treating bone fracture and preparation method | |
| CN103393961B (en) | Traditional Chinese medicine for treating cervical spondylosis and preparation method thereof | |
| CN105434818A (en) | Traditional Chinese medicine preparation for treating cervical spondylosis | |
| CN105535817A (en) | A traditional Chinese medicine composition containing argy wormwood leaves and used for treating cervical spondylosis and a preparing method thereof | |
| CN104383027A (en) | Chinese medicinal ointment with efficacies of promoting tissue regeneration and setting broken bone and preparation method thereof | |
| CN105031367A (en) | Traditional Chinese medicine preparation for treating exfoliative keratolysis | |
| CN102872211B (en) | Chinese medicine for treating epistaxis and preparation method thereof | |
| CN105641464A (en) | Traditional Chinese medicinal composition for treating pulpitis | |
| CN102716207B (en) | Medicine for treating prosopalgia and preparation method for medicine | |
| CN104027696A (en) | Traditional Chinese medicine decoction for treating chronic atrophic gastritis | |
| CN101474391B (en) | Chinese medicine for treating fracture and preparation method thereof | |
| CN106421328A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN105616721A (en) | Traditional Chinese medicine composition for treating vagina haemorrhagic syndrome and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140820 |
|
| WD01 | Invention patent application deemed withdrawn after publication |